China: GlaxoSmithKline plc Is Bribing Officials

Mani

Published onJuly 11, 2013

Updated on May 13, 2021

GlaxoSmithKline plc (ADR) (NYSE:GSK) (LON:GSK) executives have confessed to charges of bribery and tax law violations, according to China’s security ministry.

Table of Contents

GlaxoSmithKline Executives Suspected Of Offering Bribes

GlaxoSmithKline plc (ADR) (NYSE:GSK) (LON:GSK) executives are suspected of offering bribes to officials and doctors to enhance their product sales in China.

According to Chinese security ministry, GSK offered bribes to Chinese government officials, medical associations, hospitals and doctors to enhance sales and prices of their products.

Under China’s legal system, the GlaxoSmithKline plc (ADR) (NYSE:GSK)...

Login required to continue reading.

Setup a free account to get access to this article (no credit card required).

View Full Article

Already a member? Log in here

Mani

Mani is a Senior Financial Consultant. He has worked in Senior Management role in large banking, financial and information technology organizations. He has provided solutions for major banking and securities firms across the globe in the area of retail, corporate and investment banking. He holds MBA (Finance) and Professional Management Accounting Qualifications. His hobbies are tracking global financial developments and watching sports

China: GlaxoSmithKline plc Is Bribing Officials

GlaxoSmithKline Executives Suspected Of Offering Bribes

Login required to continue reading.

Get Your Business News